Biotechnology
| Sat 01 Aug 2026
Alexandria, Aug. 1 -- U.S. Patent and Trademark Office has awarded a patent to Schroedinger Inc for Heterocyclic Pericondensed CDC7 Kinase Inhibitors for the Treatment of Cancer. Boyles Nicholas, Bhat Sathesh, Huang Xianhai, Tang Haifeng, Mondal Sayan, Tang Haifeng, Greenwood Jeremy Robert, Gerasyuto Aleksey, Levinson Adam, Ghan..